Phase II trial of adjuvant gemcitabine plus cisplatin (GC) with amifostine cytoprotection in patients (pts) with locally advanced bladder cancer (BC).
Phase II trial of adjuvant gemcitabine plus cisplatin (GC) with amifostine cytoprotection in patients (pts) with locally advanced bladder cancer (BC). J Clin Oncol. 2005 Jun; 23(16_suppl):4695.